Working… Menu

A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02939807
Recruitment Status : Withdrawn (study is being rewritten for different disease population)
First Posted : October 20, 2016
Last Update Posted : September 12, 2019
National Cancer Institute (NCI)
Apogee Biotechnology Corporation
Information provided by (Responsible Party):
Medical University of South Carolina

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 30, 2023
Estimated Study Completion Date : January 30, 2024